Dunhill Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$623K Buy
677
+135
+25% +$137K 0.15% 64
2025
Q4
$541K Buy
542
+62
+13% +$59.3K 0.13% 62
2025
Q3
$367K Sell
480
-102
-18% -$75.9K 0.1% 78
2025
Q2
$454K Buy
582
+8
+1% +$6.22K 0.13% 63
2025
Q1
$474K Sell
574
-8
-1% -$6.66K 0.22% 49
2024
Q4
$449K Sell
582
-61
-9% -$50.5K 0.21% 42
2024
Q3
$570K Buy
643
+84
+15% +$75.5K 0.29% 35
2024
Q2
$506K Sell
559
-284
-34% -$227K 0.31% 33
2024
Q1
$655K Buy
843
+7
+0.8% +$4.98K 0.49% 29
2023
Q4
$487K Buy
+836
New +$488K 0.44% 26
2023
Q3
Sell
-810
Closed -$447K 82
2023
Q2
$447K Buy
+810
New +$340K 0.29% 42

Other funds holding LLY

Dunhill Financial's LLY Position: Q1 2026 in Review

Dunhill Financial increased its Eli Lilly (LLY) stake by 25% in Q1 2026, buying an estimated $137K and bringing the position to 677 shares worth $623K. The position accounts for 0.15% of the portfolio, ranked #64.

Dunhill Financial first reported a position in LLY in Q2 2023 and has held it in 11 quarters since. The position peaked at $655K in Q1 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Dunhill Financial held 677 shares of Eli Lilly worth $623K as of Q1 2026.
  • Dunhill Financial bought 135 Eli Lilly shares in Q1 2026, an estimated $137K.
  • Eli Lilly made up 0.15% of Dunhill Financial's portfolio in Q1 2026, its #64 holding.
  • Dunhill Financial first reported a position in Eli Lilly in Q2 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Eli Lilly position peaked at $655K in Q1 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.